Dec 16 2009
Platypus Technologies, developer of develops innovative products for the analytical and life sciences that utilize recent advances in nanotechnology and materials science, announces that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant for $100,000 from the National Institutes of Health.
This 1-year funded project will enable the Company to further expand its cell motility assay product line into the High Througput Screening (HTS) market. By implementing modifications to Platypus' current Oris™ 96-well cell migration assay, the Company aims to make the proposed assay compatible with automated liquid handling systems and High Content Imaging (HCI) platforms.
According to Renee Herber, Program Manager, “This is an exciting project that will dramatically improve testing throughput and efficiency, while reducing the cost per assay for researchers.” Platypus Technologies has received over $18 million in federal funding to develop cell-based assays for the study of cell motility, and LC-based nanotechnology products for environmental monitoring, infectious disease testing and homeland security.
Platypus Technologies, LLC develops innovative products for the analytical and life sciences that utilize recent advances in nanotechnology and materials science. Platypus Technologies has successfully launched several products in the Oris™ cell-based assay line that enable life science researchers to study cell migration; a process critical to a variety of in vivo processes. The Company is also developing a range of products, for diagnostic, environmental and laboratory applications, that derive from a proprietary platform technology utilizing liquid crystals for the rapid and low-cost detection of molecular interactions.